PHT Shares ePRO's Message of Improved Data Quality, Safer Trials to Scientific Audiences Worldwide
Thought Leaders from PHT Corporation deliver scientific talks about the benefits of ePRO solutions in clinical trials at industry conferences around the globe
BOSTON, MA – October 29, 2008 – PHT Corporation, the leading provider of eDiary ePRO solutions used in more than 360 clinical trials worldwide, continues to move the industry forward with it’s dominance in thought conferences.
PHT will be speaking and participating in a variety of industry conferences this fall:
• European Partnerships in Clinical Trials, November 4-7 in Berlin, Germany. PHT will exhibit at booth 33 and demonstrate its market-leading technology.
• ISPOR 11th Annual European Congress, November 8-11 in Athens, Greece. Dr. Valdo Arnera, PHT General Manager for Europe, will present poster PSY42 about e-Diary Compliance in Acute Pain Studies on Tuesday, November 11. PHT will also exhibit at booth 52.
• CBI’s 3rd Annual Forum on PRO, November 19-20 in Philadelphia, PA, USA. Dr. Jill Platko, Senior Scientist at PHT, will speak on Thursday, November 20 about Operational Analysis of Data. PHT will also be exhibiting industry-advancing technology at the conference.
• DIA 5th Latin American Congress of Clinical Research, November 20-21 in Buenos Aires, Argentina. Dr. Barbara Marino, PHT Director of Clinical Operations and Scientific Advisor, will speak about Electronic Patient Diaries in Clinical Trials: Global and Regional Experience on Thursday, November 20.
“PHT continues to lead the industry in the implementation of ePRO solutions used to capture high quality data from patients in clinical research,” said Phil Lee, President and CEO. “Presenting and exhibiting the benefits of ePRO at International and Scientific Conferences helps move the entire industry forward. PHT’s many speaking opportunities demonstrate our continued thought leadership.”
About PHT Corporation
Trust your patient and questionnaire data again. PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 360 clinical trials by 108 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient from homes and sites in 60 countries around the world. By capturing high-quality and time-stamped data, transmitted using reliable SimpleSend™ telecommunications, sponsors are able to run smaller and more conclusive clinical research programs. Meanwhile, real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 11 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.
PHT, LogPad, eSense, StudySense and SitePad are among the registered trademarks and trademarks of PHT Corporation.
Contact: Brenda Nashawaty, bnashawaty@phtcorp.com, 617-688-3253
###
